Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study

SIMPLE SUMMARY: Developing new anticancer medicaments is focused on inducing controlled elimination of tumor tissue without severe side effects. It is essential to enable the medicament to reach the target molecule without provoking the immune response too early. The first cellular changes might occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Nešić, Maja D., Dučić, Tanja, Algarra, Manuel, Popović, Iva, Stepić, Milutin, Gonçalves, Mara, Petković, Marijana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909423/
https://www.ncbi.nlm.nih.gov/pubmed/35267490
http://dx.doi.org/10.3390/cancers14051182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909423/
https://www.ncbi.nlm.nih.gov/pubmed/35267490
http://dx.doi.org/10.3390/cancers14051182

Ejemplares similares